Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Motherwort Granules (Yimucao Keli) is a traditional Chinese medicine (TCM) product manufactured by Guangzhou Nuojin Pharmaceutical. It is an over-the-counter (OTC) oral granule preparation derived from the aerial parts of *Leonurus japonicus* (Motherwort). The medicine is primarily used in gynecology to promote blood circulation, dissipate blood stasis, and regulate menstruation. It is indicated for conditions such as irregular menstruation, dysmenorrhea, and postpartum recovery, including the promotion of uterine involution and the discharge of lochia. The therapeutic effects are largely attributed to alkaloids like leonurine and stachydrine, which stimulate uterine smooth muscle contractions and improve pelvic microcirculation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on yimucao keli.